• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HUMASIS CO., LTD. DIATRUSTTM COVID-19 AG HOME TEST; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HUMASIS CO., LTD. DIATRUSTTM COVID-19 AG HOME TEST; IN VITRO DIAGNOSTICS Back to Search Results
Device Problems False Positive Result (1227); Incorrect Measurement (1383)
Patient Problem Insufficient Information (4580)
Event Date 02/05/2023
Event Type  malfunction  
Event Description
On february 8, an amazon customer commented the product was false positive.A customer got suspicious when they repeatedly tested positive for these products, and were negative on every other brand, including an unknown otc pcr test.So the user put the liquid without sample into the test cassette and it returned a positive! importer comments: due to the system functionality to not allow seller can leave the comments on the website or contact the reporter, it is not able for us to follow up to collect additional information and such as product information (lot #, expiration date, etc.) following by reporter's consent.
 
Event Description
On february 8, an amazon customer commented the product was false positive.A customer got suspicious when they repeatedly tested positive for these products, and were negative on every other brand, including an unknown otc pcr test.So the user put the liquid without sample into the test cassette and it returned a positive! importer comments: due to the system functionality to not allow seller can leave the comments on the website or contact the reporter, it is not able for us to follow up to collect additional information and such as product information (lot #, expiration date, etc.) following by reporter's consent.Follow-up 1: on february 14, celltrion first reported it as 3008719759-2023-00021.On february 11th, this user also reported this incident directly to the medwatch 3500a to the fda (mdr# mw5114929) and the fda forwarded it to nephron pharmaceuticals, listed as the manufacturer in mw5114929.On february 17, nephron received an email with mw5114929 attached from fda, determined that the report was a celltrion product, and informed celltrion by forwarding the the fda email with mw5114929 on the same day.Celltrion confirmed that the already reported 3008719759-2023-00021 was the same case as mw5114929 through a follow-up to the initial reporter.However, because the user discarded the product before becoming aware of the false positive, the reporter could not provide product details such as batch number, and therefore celltrion would like to inform the fda that it is no longer able to investigate the product.We will update this follow-up mdr to the manufacturer for reference.Please refer to the attached medwatch (mw5114929).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIATRUSTTM COVID-19 AG HOME TEST
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
HUMASIS CO., LTD.
88, jeonpa-ro
dongan-gu
anyang-si, gyeonggi-do 14042
KS  14042
MDR Report Key16372413
MDR Text Key309494484
Report Number3008719759-2023-00021
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/14/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/17/2023
Event Location Home
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-